Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA GLENMARK PHARMA ABBOTT INDIA/
GLENMARK PHARMA
 
P/E (TTM) x 52.6 -30.3 - View Chart
P/BV x 19.1 2.8 695.1% View Chart
Dividend Yield % 1.1 0.3 423.3%  

Financials

 ABBOTT INDIA   GLENMARK PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-23
GLENMARK PHARMA
Mar-23
ABBOTT INDIA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs22,482487 4,615.0%   
Low Rs16,156349 4,630.6%   
Sales per share (Unadj.) Rs2,517.0460.4 546.8%  
Earnings per share (Unadj.) Rs446.813.4 3,340.4%  
Cash flow per share (Unadj.) Rs479.735.0 1,369.1%  
Dividends per share (Unadj.) Rs325.002.50 13,000.0%  
Avg Dividend yield %1.70.6 281.3%  
Book value per share (Unadj.) Rs1,480.5335.1 441.8%  
Shares outstanding (eoy) m21.25282.17 7.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.70.9 845.2%   
Avg P/E ratio x43.231.3 138.3%  
P/CF ratio (eoy) x40.311.9 337.5%  
Price / Book Value ratio x13.01.2 1,046.1%  
Dividend payout %72.718.7 389.2%   
Avg Mkt Cap Rs m410,513117,953 348.0%   
No. of employees `000NANA-   
Total wages/salary Rs m5,63627,810 20.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,487129,901 41.2%  
Other income Rs m1,5433,168 48.7%   
Total revenues Rs m55,030133,069 41.4%   
Gross profit Rs m12,05515,125 79.7%  
Depreciation Rs m7006,113 11.4%   
Interest Rs m1603,496 4.6%   
Profit before tax Rs m12,7388,685 146.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,2444,911 66.1%   
Profit after tax Rs m9,4943,774 251.6%  
Gross profit margin %22.511.6 193.6%  
Effective tax rate %25.556.5 45.0%   
Net profit margin %17.82.9 611.0%  
BALANCE SHEET DATA
Current assets Rs m30,25198,737 30.6%   
Current liabilities Rs m12,06050,455 23.9%   
Net working cap to sales %34.037.2 91.5%  
Current ratio x2.52.0 128.2%  
Inventory Days Days877 1,296.7%  
Debtors Days Days2115 1.9%  
Net fixed assets Rs m15,13576,920 19.7%   
Share capital Rs m213282 75.3%   
"Free" reserves Rs m31,24894,281 33.1%   
Net worth Rs m31,46094,563 33.3%   
Long term debt Rs m038,521 0.0%   
Total assets Rs m45,386175,658 25.8%  
Interest coverage x80.73.5 2,315.1%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.20.7 159.4%   
Return on assets %21.34.1 514.0%  
Return on equity %30.24.0 756.2%  
Return on capital %41.09.2 448.0%  
Exports to sales %0.40-   
Imports to sales %10.80-   
Exports (fob) Rs m221NA-   
Imports (cif) Rs m5,765NA-   
Fx inflow Rs m31046,464 0.7%   
Fx outflow Rs m5,81812,712 45.8%   
Net fx Rs m-5,50833,751 -16.3%   
CASH FLOW
From Operations Rs m8,9346,254 142.9%  
From Investments Rs m-1,477-5,285 27.9%  
From Financial Activity Rs m-6,387-775 824.6%  
Net Cashflow Rs m1,070325 329.1%  

Share Holding

Indian Promoters % 0.0 46.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.9 34.7 25.7%  
FIIs % 0.2 23.7 0.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 53.4 46.9%  
Shareholders   72,252 209,931 34.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Abbott India vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs Glenmark Pharma Share Price Performance

Period Abbott India Glenmark Pharma S&P BSE HEALTHCARE
1-Day -0.93% -1.70% -0.98%
1-Month -4.03% 7.03% -5.03%
1-Year 33.07% 107.45% 57.44%
3-Year CAGR 24.28% 26.25% 18.14%
5-Year CAGR 31.00% 7.41% 18.88%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 325.0 per share. This amounted to a Dividend Payout ratio of 72.7%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of Abbott India, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.